PIAS3 and colorectal carcinoma: Upregulation of PIAS3 could contribute to promoting the expression level of IGF-1R that in turn leading to Wnt pathway activation and thus causing resistance to chemotherapeutic agents. IGF-1R and PIAS3 knockdown via siRNAs leading to the chemotherapy sensitivity in CRC cells.